|
TMEM168 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.180000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.062720E-03 |
| Normal-vs-Stage2 |
1.040850E-03 |
| Normal-vs-Stage3 |
7.80860000000327E-05 |
| Normal-vs-Stage4 |
2.997600E-02 |
| Stage1-vs-Stage2 |
4.371400E-01 |
| Stage1-vs-Stage3 |
2.163200E-01 |
| Stage1-vs-Stage4 |
9.264400E-01 |
| Stage2-vs-Stage3 |
7.806200E-01 |
| Stage2-vs-Stage4 |
4.872600E-01 |
| Stage3-vs-Stage4 |
3.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.240230E-03 |
| Normal-vs-AfricanAmerican |
2.362500E-03 |
| Normal-vs-Asian |
5.378200E-01 |
| Caucasian-vs-AfricanAmerican |
9.135800E-01 |
| Caucasian-vs-Asian |
3.333400E-01 |
| AfricanAmerican-vs-Asian |
3.054800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.983600E-04 |
| Normal-vs-Female |
1.854350E-02 |
| Male-vs-Female |
2.579400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.799600E-03 |
| Normal-vs-Extreme_Weight |
1.879760E-03 |
| Normal-vs-Obese |
7.020000E-04 |
| Normal-vs-Extreme_Obese |
2.344400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.551600E-01 |
| Normal_Weight-vs-Obese |
9.755400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.736400E-01 |
| Extreme_Weight-vs-Obese |
7.247400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.179000E-01 |
| Obese-vs-Extreme_Obese |
7.444200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.359600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.436130E-02 |
| Normal-vs-Age(61-80Yrs) |
1.624100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.208200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.006000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.704000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.069600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.498000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.476000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.559800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.243400E-03 |
| Normal-VS-Type2 PRCC |
3.35500000003819E-07 |
| Normal-VS-KIRP CIMP |
7.179900E-04 |
| Normal-VS-Unclassified PRCC |
4.204100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.573300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.438200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.169200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.905600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.959600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.706820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83040000051516E-07 |
| Normal-vs-N1 |
1.275140E-03 |
| Normal-vs-N2 |
4.344000E-02 |
| N0-vs-N1 |
3.478800E-01 |
| N0-vs-N2 |
9.138600E-01 |
| N1-vs-N2 |
6.102800E-01 |
|
|
